Literature DB >> 23903550

Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopy.

Christine White1, Helen Keegan, Loretto Pilkington, Carmel Ruttle, Patrick Kerr, Linda Sharp, Sharon O'Toole, Michael Turner, Walter Prendiville, Tom D'Arcy, Myra Fitzpatrick, Peter Lenehan, Grainne Flannelly, John J O'Leary, Cara M Martin.   

Abstract

The clinical performance of the cobas human papillomavirus (HPV) test for detection of high-grade disease in a colposcopy-referred population was compared with that of Hybrid Capture 2 (HC2). The overall agreement between the tests was 92.3%. Clinical sensitivity and specificity for detection of cervical intraepithelial neoplasia grade 2 or greater (CIN2+) were 90.0% and 55.5% for cobas and 90.5% and 50.2% for HC2, respectively. In conclusion, both tests showed comparable performance for detection of CIN2+.

Entities:  

Mesh：

Year:  2013        PMID： 23903550      PMCID： PMC3811647          DOI： 10.1128/JCM.01949-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail.

Authors:  Mario Poljak; Irena J Marin; Katja Seme; Adriana Vince
Journal:  J Clin Virol       Date:  2002-12       Impact factor: 3.168

2.  Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.

Authors:  Julia C Gage; Mark Sadorra; Brandon J Lamere; Randi Kail; Carrie Aldrich; Walter Kinney; Barbara Fetterman; Thomas Lorey; Mark Schiffman; Philip E Castle
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

3.  Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.

Authors:  Maria Luisa Mateos Lindemann; Mario Jose Rodriguez Dominguez; Jesús Chacón de Antonio; Maria Teresa Sandri; Alessio Tricca; Mario Sideri; Hacène Khiri; Sophie Ravet; Sean Boyle; Carrie Aldrich; Philippe Halfon
Journal:  J Mol Diagn       Date:  2011-11-10       Impact factor: 5.568

4.  Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix.

Authors:  Simon Grandjean Lapierre; Philippe Sauthier; Marie-Hélène Mayrand; Simon Dufresne; Patrick Petignat; Diane Provencher; Pierre Drouin; Philippe Gauthier; Marie-Josée Dupuis; Bertrand Michon; Stéphan Ouellet; Rachid Hadjeres; Alex Ferenczy; Eduardo L Franco; François Coutlée
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

5.  High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study.

Authors:  Mark H Stoler; Thomas C Wright; Abha Sharma; Raymond Apple; Karen Gutekunst; Teresa L Wright
Journal:  Am J Clin Pathol       Date:  2011-03       Impact factor: 2.493

6.  2006 consensus guidelines for the management of women with abnormal cervical screening tests.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925
  6 in total
  2 in total

1.  Sputasol (Dithiothreitol 0.54%) Improves the Detection of Human Papillomaviruses Using the Cobas 4800 System.

Authors:  Qing Yong Wang; He Rui Zhang; Yu Gao; Rong Hai Li; Xiao Hong Shang
Journal:  Ann Lab Med       Date:  2017-09       Impact factor: 3.464

2.  The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.

Authors:  Júlio C Possati-Resende; José H T G Fregnani; Ligia M Kerr; Edmundo C Mauad; Adhemar Longatto-Filho; Cristovam Scapulatempo-Neto
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.